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Protocol title: UK Consensus Project on Quality in Palliative Care Day Services 
 
 
Summary  
 
The UK Consensus Project on Quality in Palliative Care Day Services is funded by Marie 
Curie and based at Queen’s University, Belfast. It is being carried out in collaboration with a 
number of other academic institutions and key stakeholder organizations. The project will 
involve and take into account the perspectives of a range of different stakeholders and its 
outcomes will be relevant to patients, family members, palliative care professionals, and 
policy makers. The aim is to use an expert consensus process to develop a set of quality 
indicators for assessment of all aspects [structure, process and outcomes] of quality of care in 
Palliative Care Day Services. This expert panel will include around 20 people from all over the 
UK who work in, or have experience of day services. The panel will include a wide range of 
different professionals and volunteers, as well as people who have experience of attending 
day services as a patient, a carer or family member.      
 
Agreement on a quality indicator set will be reached using the RAND/UCLA Appropriateness 
Method [1], a method of reaching consensus based on differing opinions. The first stage of the 
process will involve a panel of 20 experts individually considering and rating the 
appropriateness of potential quality indicators. Ratings will be based on their own experience 
and knowledge, as well as a series of evidence summary tables drawn up based on a 
systematic review carried out to identify existing indicators relevant to palliative care day 
services.  
 
Ratings will be analysed and summarised in advance of the second round, at an expert panel 
meeting. At this meeting quality indicators and their preliminary ratings will be discussed and 
re-rated. All ratings will be made anonymously. Unlike other consensus development 
processes, complete agreement is not required. During the meeting, discussions will be 
focused specifically on any areas of disagreement, in order to understand how and why the 
variation was found. Indicators will be considered to be “appropriate” if they have a median 
rating of 7 or more without disagreement. Disagreement will be defined as more than 30% of 
panel members give a rating of 3 or less to a potential indicator. An indicator will be 
considered as “not appropriate” if its median score is 3 or less without disagreement 
(disagreement being when 30% or more of the ratings are 7 or more). When the median 
rating is between 4 and 6, or if disagreement is observed, the appropriateness of the indicator 
will be considered as uncertain and it will be discussed at the panel meeting. The following 
options will be offered to the panel members: acceptance of a quality indicator, rejection or 
adjustment of a quality indicator, and merging multiple indicators into a single quality 
indicator. 
 
Panel members will also be asked to identify additional indicators not on the original list, 
modify existing indicators that may require re-wording and remove those perceived to be 
irrelevant. Following this discussion, a revised list of indictors will be developed, and panel 
members will re-rate the appropriateness of each. Panel members will also be asked to rate 
the feasibility or practicability of measuring each indicator in a typical day service setting using 
the same 9-point scale. At the end of the process, a set of quality indicators will be developed 
that passed the first round of individual rating as well as the second-round discussion. This 
set of quality indicators will be sent to the expert panel by e-mail after the meeting, as well as 
to other stakeholders, for final approval.  
 
Following this, further work will be conducted to develop and test the suitability of a toolkit 
which can be used to measure quality indicators in palliative care day services. 
 
 
[1] Fitch K, Bernstein SJ, Aguilar MD, et al. The RAND/UCLA Appropriateness Method User's 
Manual. Santa Monica, CA: RAND Corporation, 2001. 
http://www.rand.org/pubs/monograph_reports/MR1269.  
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Purpose 
 
1) Development of a set of quality indicators (QIs) for the assessment of all aspects 
(structure, process and outcome) of quality of care of Palliative Care Day Services 
(PCDS) 
2) Development and implementation of a toolkit for assessment of QIs in PCDS 
 
Ultimately, with the assistance of our expert panels we will seek support from palliative care 
providers and umbrella organisations for the adoption of the QI toolkit in practice and further 
pilot testing. Whilst economic analysis is beyond the scope of this project, findings from the 
project will provide information that will be useful in taking forward full economic evaluations 
of hospice day services.  
 
 
Research Plan 
 
1. Quality of Care Indicators in PCDS 
 
There is little consensus around those aspects of care which should be used to evaluate 
PCDS, and NICE25 were unable to provide guidance about a best model of practice. 
Furthermore, there has been no attempt to develop quality indicators (QIs) for PCDS, and the 
evidence base in the area is generally weak. Yet, service providers are under pressure to 
demonstrate the value and cost-effectiveness of PCDS in a climate where an ageing 
population and increasing burden of life limiting illness will lead to increasing demand on 
these services. The development and implementation of common indicators for PCDS would 
provide service-providers and commissioners with a means of defining, measuring and 
comparing the quality of key aspects of care –and in a way that adjusts for demographic, 
patient-related and external factors, variation across settings and in mode of delivery.26,27 
Quality indicators may be used to stimulate, motivate and evaluate initiatives to improve 
patient care and may help to target resources in an appropriate and effective way27. 
Furthermore QIs may be aggregated and analysed in ways to test the justification of services, 
and secure resources from funders and commissioners.28 
Existing quality indicators in palliative care and their methodological specifications are not well 
specified, and generally have not followed a rigorous or standardised process of 
development.26,27 The Q-PAC study29 in Belgium is the first to apply a scientifically rigorous 
method to develop a comprehensive and valid quality indicator set for palliative care and to 
include all three major areas of health care (structure, process and outcome).There are 
currently no published QIs for PCDS across the international literature. Whilst existing 
indicators for general palliative care26,27,30 and other specific healthcare settings31-33 provide a 
valuable starting point for the identification and specification of appropriate QIs for PCDS, 
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there is a need to adapt and supplement these for use in the UK27,28, and to adequately reflect 
the goals of PCDS - with its focus on early intervention, social care, rehabilitation, and its 
more diverse population. The inclusion of structure and process indicators is particularly key 
in palliative care27,29 where patients’ health may be deteriorating and not all aspects of quality 
care will be reflected in outcomes that are readily quantifiable, or may require more creative 
methods of assessment. 34 
 
Work Package 1 will identify using rigorous methods, a set of QIs for UK PCDS, 
incorporating assessment of structure, process and outcome. 
 
2. Feasibility of Quality Indicators 
 
QIs need to be clinically relevant and should be operationalised in a way that is amenable to 
assessment, ideally as part of routine practice.35,36 Hence, it is key that QIs are developed 
alongside user instructions37 incorporating definitions, appropriate inclusion / exclusion criteria 
(to account for complexity of care, variety of patient preference and variation in populations), 
so that they are not analysed or represented inappropriately or misinterpreted by decision 
makers. The burden of their implementation also needs to be assessed. Whilst outcome 
measurements completed directly with users are most informative44, issues of burden and 
practicality need to be assessed. Databases provide a cheaper and easier option for 
collecting information around QIs – but may be limited in terms of data quality, completeness 
and ability to assess all aspects of care.28 
 
Work Package 2 will result in a toolkit to support the assessment of QIs and test their 
feasibility and acceptability in applied settings across the UK. 
 
 
Methods 
 
Work Package 1:  
The RAND /UCLA method40 is the only systematic method for selecting QIs which combines 
best available scientific evidence with the collective judgement of expert stakeholders.  
The RAND / UCLA method specifies the following stages and suggested timescales40: 
 
1. An international literature review, development of a conceptual model and 
review of evidence base for indicators. The research team will identify candidate 
indicators from existing research literature and strategy documents in palliative care 
(internationally), and from synthesised potential ‘read across’ lessons associated with 
forms of day time services for other patient groups such as older people and people 
with disabilities. This will result in a set of candidate indicators and a preliminary 
model relating these indicators to aspects of care and patient outcomes. The 
research team will also produce summaries of the evidence for each indicator and its 
relationship with quality of care / patient outcomes, using the AIRE instrument41. 
 
2. Panel reviews. Relevant palliative care national umbrella organisations, networks, 
professional organisations, patient organisations, and service-user groups will be 
asked to nominate individuals from across the UK to contribute to two expert (one 
‘professional’ and one ‘service-user panel) (at least nine members each). The panel 
compositions will optimise geographic diversity and diversity of practice setting. The 
panels will be tasked with rating the appropriateness of each of the draft indicators for 
assessing quality of care of PCDS, and identification of missing indicators. Each 
panel review consists of a two stage process: 
a. the indicators are assessed as measures of quality within a postal survey by 
asking each member to rate the appropriateness of each indicator. Panellists 
receive the evidence summaries, draft measures, ballots, and instructions. 
Lay summaries, used in previous research29’42 will be produced for the expert 
service-user panel. 
b. a face-to-face panel meeting bringing the panel together from across the UK. 
Members of the research team will moderate discussions of each draft 
indicator, the evidence, and first-round ratings using a modified-Delphi panel 
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method. Each panellist receives a summary of the first-round ratings for each 
indicator, their rating relative to the distribution, and the analytic 
interpretation. After all opinions have been voiced for an indicator, each 
panellist is asked to rate the appropriateness of the quality indicator again. 
The RAND / UCLA method provides clear definitions and criteria for the 
calculation of ‘appropriateness’. Only measures that are judged appropriate 
will be included in the later stages of the project. Following this discussion a 
final stage will ask panellists to rate (for each ‘appropriate’ QI) whether the 
related aspect of care is also ‘necessary’. This will provide an indication of 
those quality indicators that are core and others that could be considered 
supplementary. 
  
3. Operationalisation and risk adjustment. The most appropriate instruments / data 
for measuring the indicators will be selected by reviewing the research literature and 
the work of groups such as PRISMA, MoReCare and the EAPC taskforce on patient-
reported outcome measurement in palliative care – which are involved with the 
harmonisation of approaches to outcome measurement in palliative care. These 
groups however are not currently tasked with identifying process and structural 
elements of care and the current project will be novel in this regard. 
Operationalisation of structural and process indicators (specifying what information 
should be collected, how it should be presented, analysed and interpreted) will be 
informed by the expert panel discussions, the project advisory board, and literature 
(where available). In addition, risk adjustment will identify those patient-related and 
other factors which should be considered alongside QIs or where exclusions should 
be applied. A summary of the QIs, their operationalisation, and risk adjustment will be 
sent to the expert panels for comment.  
 
4. Finalisation of specifications. The feedback from the expert panels will be 
incorporated into the quality framework and a final set of quality indicators produced, 
incorporating operationalisation and risk adjustment. 
 
5. User documentation. A draft toolkit for use in practice will be produced – 
incorporating an instruction manual (what data to collect and from what source(s)), 
definitions, data collection forms (including questionnaires where appropriate), how to 
treat missing data, instructions on analysing and presenting results.  
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